Expression Analysis (EA) Purchases Its First Illumina Genome Analyzer

Illumina (NASDAQ:ILMN) today announced that Expression Analysis, an Illumina certified service provider (CSPro) and leading supplier of genotyping, gene expression, and resequencing services for genetic research, purchased its first Genome Analyzer. With this purchase, Expression Analysis becomes the only CSPro that owns all four of Illumina’s genomic research platforms: Genome Analyzer, iScan, BeadStation, and BeadXpress. This means that customers can perform truly integrated genetic analysis studies, from whole-genome to targeted screening.

Source: Illumina